[go: up one dir, main page]

JPS5488268A - Novel imidazole derivatives*their manufacture and medical composition - Google Patents

Novel imidazole derivatives*their manufacture and medical composition

Info

Publication number
JPS5488268A
JPS5488268A JP12830378A JP12830378A JPS5488268A JP S5488268 A JPS5488268 A JP S5488268A JP 12830378 A JP12830378 A JP 12830378A JP 12830378 A JP12830378 A JP 12830378A JP S5488268 A JPS5488268 A JP S5488268A
Authority
JP
Japan
Prior art keywords
manufacture
medical composition
imidazole derivatives
novel imidazole
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP12830378A
Other languages
Japanese (ja)
Other versions
JPS6233227B2 (en
Inventor
Buraian Sorogutsudo Piitaa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Publication of JPS5488268A publication Critical patent/JPS5488268A/en
Publication of JPS6233227B2 publication Critical patent/JPS6233227B2/ja
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D319/00Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/101,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/141,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/161,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/201,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring with substituents attached to the hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/485Morphinan derivatives, e.g. morphine, codeine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C17/00Preparation of halogenated hydrocarbons
    • C07C17/093Preparation of halogenated hydrocarbons by replacement by halogens
    • C07C17/16Preparation of halogenated hydrocarbons by replacement by halogens of hydroxyl groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/84Sulfur atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP12830378A 1977-10-19 1978-10-18 Novel imidazole derivatives*their manufacture and medical composition Granted JPS5488268A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB4351277 1977-10-19
GB4353277 1977-10-19
GB398478 1978-02-01

Publications (2)

Publication Number Publication Date
JPS5488268A true JPS5488268A (en) 1979-07-13
JPS6233227B2 JPS6233227B2 (en) 1987-07-20

Family

ID=27254350

Family Applications (1)

Application Number Title Priority Date Filing Date
JP12830378A Granted JPS5488268A (en) 1977-10-19 1978-10-18 Novel imidazole derivatives*their manufacture and medical composition

Country Status (12)

Country Link
JP (1) JPS5488268A (en)
AT (1) AT370095B (en)
AU (1) AU522055B2 (en)
CA (1) CA1111433A (en)
DE (1) DE2845406A1 (en)
DK (1) DK464278A (en)
FI (1) FI783175A7 (en)
IE (1) IE47749B1 (en)
IL (1) IL55858A (en)
IT (1) IT1109321B (en)
MC (1) MC1221A1 (en)
ZA (1) ZA785863B (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5681566A (en) * 1979-12-05 1981-07-03 Yoshitomi Pharmaceut Ind Ltd Imidazole derivative
JPS5953470A (en) * 1982-08-14 1984-03-28 ザ・ウエルカム・フアウンデ−シヨン・リミテツド Imidazole derivative
JPH01316365A (en) * 1988-03-24 1989-12-21 Shikoku Chem Corp 1-benzylimidazole compound, synthesis thereof and curing of polyepoxy resin using said compound

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55313A (en) * 1978-06-13 1980-01-05 Kissei Pharmaceut Co Ltd Imidazole derivative
US4430445A (en) 1979-07-19 1984-02-07 Asahi Kasei Kogyo Kabushiki Kaisha Novel basic imidazolylmethylstyrene compound, its polymer, a process for the preparation thereof and a use as ion exchange resin
JPS6047257B2 (en) * 1979-07-19 1985-10-21 旭化成株式会社 Novel basic substances and their production methods
GR78234B (en) * 1981-03-10 1984-09-26 Ciba Geigy Ag
JPS57188570A (en) * 1981-05-14 1982-11-19 Shionogi & Co Ltd Benzylazole derivative
US4581370A (en) * 1983-07-12 1986-04-08 Schering A.G. Antiarrhythmic imidazoliums
JPH0172006U (en) * 1987-10-31 1989-05-15

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5681566A (en) * 1979-12-05 1981-07-03 Yoshitomi Pharmaceut Ind Ltd Imidazole derivative
JPS5953470A (en) * 1982-08-14 1984-03-28 ザ・ウエルカム・フアウンデ−シヨン・リミテツド Imidazole derivative
JPH01316365A (en) * 1988-03-24 1989-12-21 Shikoku Chem Corp 1-benzylimidazole compound, synthesis thereof and curing of polyepoxy resin using said compound

Also Published As

Publication number Publication date
MC1221A1 (en) 1979-07-20
DE2845406A1 (en) 1979-05-03
AT370095B (en) 1983-02-25
IT1109321B (en) 1985-12-16
ZA785863B (en) 1980-05-28
ATA747378A (en) 1982-07-15
CA1111433A (en) 1981-10-27
AU4082478A (en) 1980-04-24
IE782067L (en) 1979-04-19
JPS6233227B2 (en) 1987-07-20
IT7851570A0 (en) 1978-10-18
IL55858A (en) 1982-09-30
FI783175A7 (en) 1979-04-20
AU522055B2 (en) 1982-05-13
IE47749B1 (en) 1984-06-13
DK464278A (en) 1979-04-20
IL55858A0 (en) 1979-01-31

Similar Documents

Publication Publication Date Title
JPS5318557A (en) Novel aminoalkylfuran derivatives* their preparation and medical composition containing same
JPS53144568A (en) Novel aminoalkylthiophene derivatives* their production* medical compositions containing same and their medical uses
NZ188140A (en) Nitroimidazole derivatives and pharmaceutical compositions
ZA781218B (en) Novel substituted phenoxybenzyloxycarbonyl derivatives and their use as insecticides and acaricides
JPS5455568A (en) 11substituted imidazoles and pharmaceutical composition
JPS5441881A (en) Aminopyridine derivatives*their manufacture and medical composition containing it
JPS5481266A (en) 11alkanoyllpyrroline derivatives*manufacture and use
JPS5473768A (en) Novel pyrrole derivatives*their manufacture and therapeutic composition containing them
NZ188976A (en) Prostacyclin derivatives and pharmaceutical compositions
JPS5476583A (en) Novel derivatives of triazole*their manufacture and antiiallergic medical composition
JPS5473784A (en) Substituted quinolylguanidine derivatives and their manufacture and use
JPS55115872A (en) Imidazole derivative and medical composition
JPS542341A (en) Medical composition
JPS5466675A (en) Omegaamercaptopropionamido*its manufacture and medical composition
JPS5488268A (en) Novel imidazole derivatives*their manufacture and medical composition
JPS55120583A (en) Pyrazole derivatives*their medical composition and their manufacture
JPS57118543A (en) Novel benzenecarboxyamide derivatives, manufacture and medicinal composition
JPS5473765A (en) Novel 66oxidatedd3*200dioxoopregnane derivatives*their manufacture and medical composition containing said compounds
JPS5461167A (en) Novel substituted heterocyclic compounds* their manufacture and medical composition containing them
JPS5428829A (en) Antiithrombosis medical composition
JPS5481284A (en) 22substituted piperazine*its manufacture and its medical composition
GB2001978B (en) Pyranochromone derivatives and therapeutic compositions
JPS5481269A (en) 11*naphthylethyl*imidazole derivatives*their manufacture and medical composition containing them
NZ186410A (en) Imidazole derivatives and pharmaceutical compositions
JPS5490167A (en) Novel tetracyclononane derivative*its manufacture and antivirulent medical composition containing it